1. DIYTechnicalAnalysis is a private community of traders and investors interested in building wealth from Indian equity market. You can become a member with a one time registration fee of ₹199. Click here to become a member

Trigger for Pharma Sector

Discussion in 'Technical Analysis' started by shabbir, Jan 2, 2018.

Tags:
  1. shabbir

    shabbir Administrator Staff Member

    Joined:
    Apr 30, 2012
    Messages:
    6,703
    Likes Received:
    1,940
    shabbir, Jan 2, 2018
    Share #1
  2. sudheerpal2

    sudheerpal2 New Member

    Joined:
    Sep 6, 2016
    Messages:
    10
    Likes Received:
    4
    This is negative for pharma...right?
     
    sudheerpal2, Jan 2, 2018
    Share #2
  3. shabbir

    shabbir Administrator Staff Member

    Joined:
    Apr 30, 2012
    Messages:
    6,703
    Likes Received:
    1,940
    This is positive for large cap pharma companies because now they will have more products that can be sold in US. Again it can be viewed as more competition as well but that isn't how I like to see it. More drugs being approved doesn't mean every company will have drug in that segment to be sold in US.
     
    shabbir, Jan 2, 2018
    Share #3
    rbathri likes this.